News

Healio1d
Nerandomilast lowers FVC decline in progressive pulmonary fibrosis at 52 weeks
Two doses of 52-week nerandomilast, a phosphodiesterase 4B inhibitor, lowered FVC decline vs. placebo in patients with ...
European Medical Journal1d
CT Metrics Predict ALS Survival as Well as Traditional Spirometry
Understand how CT metrics match FVC in predicting ALS survival, offering a spirometry alternative for patients with bulbar ...